Logos Global Management »

Disc Medicine shares owned by Logos Global Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $42M 925k 45.07
2023-03-31 $11M 525k 21.19

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Disc Medicine

Paradigm Biocapital Advisors
Atlas Venture Life Science Advisors
Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
BlackRock
T. Rowe Price Associates
Vanguard Group
Deerfield Management Company
Logos Global Management
Point72 Asset Management
Wellington Management Company
State Street Corporation
Adage Capital Partners GP
Perceptive Advisors

View all funds holding Disc Medicine